Catalyst Pharmaceuticals Inc (CPRX)
Number of days of payables
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Payables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
Number of days of payables | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ —
= —
The data provided for Catalyst Pharmaceuticals Inc indicates that the number of days of payables is not available for any of the reported periods from March 31, 2020, to December 31, 2024. This makes it challenging to analyze the company's efficiency in paying its suppliers within a specific timeframe.
The number of days of payables is a key financial metric that helps in assessing how long a company takes to pay its suppliers for the goods or services it has received. A lower number of days of payables may indicate a better liquidity position as the company is paying its bills more quickly, but it could also suggest that the company is missing out on potential opportunities to optimize its cash flow by paying later.
Without the specific data on the number of days of payables for Catalyst Pharmaceuticals Inc, it is difficult to draw any conclusions regarding the company's payment practices and its impact on its financial health. It would be beneficial for the company to disclose this information in future financial reports to provide a more comprehensive view for stakeholders and analysts evaluating the company's operational efficiency and working capital management.
Peer comparison
Dec 31, 2024